Clinical Trial Update: Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of evogliptin added to metformin in patients with type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin (evogliptin)
• metformin (metformin)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED